Orchard Therapeutics hits up Hitachi CDMO to make autologous gene therapy – BioPharma-Reporter.com
Orchard Therapeutics hits up Hitachi CDMO to make autologous gene therapyBioPharma-Reporter.comUnder terms of the deal, PCT will make clinical supplies of OTL-101, an autologous ex-vivo gene therapy for the treatment of adenosine deaminase deficiency s… Continue reading
